Cabaletta Bio Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	116.64	82.98	163.96	193.24	81.61	122.22
Short-Term Investments	-	50.62	-	48.01	24.94	-
Cash & Short-Term Investments	116.64	133.6	163.96	241.25	106.55	122.22
Cash Growth	-11.53%	-18.52%	-32.04%	126.43%	-12.83%	12.48%
Other Current Assets	5.68	5.27	2.71	3.24	2.29	2.32
Total Current Assets	122.32	138.87	166.68	244.49	108.83	124.54
Net Property, Plant & Equipment	20.56	21.05	16.08	7.45	7.57	1.44
Other Long-Term Assets	5.27	5.16	2.29	1.71	0.57	0.36
Total Assets	148.15	165.08	185.05	253.65	116.97	126.34
Accounts Payable	6.38	6.64	4.92	4.55	2.46	2.33
Accrued Expenses	12.01	19.3	12.19	7.89	4.85	6.05
Current Portion of Leases	23.12	24.22	9.98	3.56	2.18	-
Total Current Liabilities	41.51	50.15	27.09	15.99	9.49	8.38
Long-Term Leases	3.33	2.88	5.63	1.46	2.96	-
Total Long-Term Liabilities	3.33	2.88	5.63	1.46	2.96	-
Total Liabilities	44.84	53.03	32.71	17.45	12.45	8.38
Common Stock	0	0	0	0	-	-
Additional Paid-in Capital	663.78	628.98	501.44	469.4	270.13	230.54
Accumulated Other Comprehensive Income	-	0.03	-	0.04	-0.05	-
Retained Earnings	-560.47	-516.96	-349.1	-233.24	-165.56	-112.59
Shareholders' Equity	103.31	112.05	152.34	236.2	104.52	117.96
Total Liabilities & Equity	148.15	165.08	185.05	253.65	116.97	126.34
Total Debt	26.45	27.1	15.6	5.02	5.14	0
Net Cash (Debt)	90.19	106.5	148.36	236.23	101.41	122.22
Net Cash Growth	-15.32%	-28.21%	-37.20%	132.95%	-17.03%	12.48%
Net Cash Per Share	0.95	1.33	3.00	5.76	3.46	4.75
Book Value	103.31	112.05	152.34	236.2	104.52	117.96
Book Value Per Share	1.09	1.40	3.08	5.76	3.57	4.58
Tangible Book Value	103.31	112.05	152.34	236.2	104.52	117.96
Tangible Book Value Per Share	1.09	1.40	3.08	5.76	3.57	4.58

SEC Filings: 10-K · 10-Q